Effect of sympathoinhibition on exercise performance in patients with heart failure

Circulation

Volumn 96, Issue 1, 1997, Pages 238-245

  Lang, Chim C ^a   Rayos, Glenn H ^a   Chomsky, Don B ^a   Wood, Alastair J J ^a   Wilson, John R ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Catecholamines; Clonidine; Exercise; Heart failure; Muscles; Regional blood flow

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; EXERCISE; HEART FAILURE; HEART INNERVATION; HEART PERFORMANCE; HUMAN; PRIORITY JOURNAL; SYMPATHETIC TONE; TREATMENT OUTCOME;

EID: 0030854768     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.1.238     Document Type: Article

References (36)

1. 2 transport and ventilatory abnormalities. Am J Cardiol. 1983;51:1358-1363.
2. Massie BM. Exercise tolerance in congestive heart failure. Am J Med. 1988;84(suppl 3A):75-82.
3. Liang C, Stewart DK, LeJemtel TH, Kirlin PC, Mcintyre KM, Robertson HT, Brown R, Moore AW, Wellington KL, Cahill L, Galvao MN, Woods PA, Graces C, Held P. Characteristics of peak aerobic capacity in symptomatic and asymptomatic subjects with left ventricular dysfunction. Am J Cardiol. 1992;69:1207-1211.
4. Levine TB, Francis GS, Goldsmith SR, Simon A, Cohn JN. Activity of the sympathetic nervous system and renin angiotensin system assessed by plasma hormone levels and their relationship to hemodynamic abnormalities in congestive heart failure. Am J Cardiol. 1982;49:1659-1666.
5. Leimbach WN, Wallin G, Victor RG, Aylward PE, Sundlof G, Mark AL. Direct evidence from intraneuronal recordings for increased central sympathetic outflow in patients with heart failure. Circulation. 1986;73:913-919.
6. Chidsey CA, Harrison DC, Braunwald E. Augmentation of the plasma norepinephrine response to exercise in patients with congestive heart failure. N Engl J Med. 1962;267:650-654.
7. Francis GS, Goldsmith SR, Ziesche SM, Cohn JN. Response of plasma norepinephrine and epinephrine to dynamic exercise in patients with congestive heart failure. Am J Cardiol. 1982;49: 1152-1156.
8. Zelis R, Nellis SH, Longhurst J, Lee G, Mason DT. Abnormalities in the regional circulation accompanying congestive heart failure. Prog Cardiovasc Dis. 1975;28:181-199.
9. Drexler H. Reduced exercise tolerance in chronic heart failure and its relationship to neurohormonal factors. Eur Heart J. 1991; 12(suppl C):21-28.
10. Richter EA, Ruderman NB, Galbo H. Alpha and beta adrenergic effects on metabolism in contracting, perfused muscle. Acta Physiol Scand. 1982;116:215-222.
11. Stainsby WN, Sumners C. Eitzman PD. Effects of catecholamines on lactic acid output during progressive working contractions. J Appl Physiol. 1985;59:1809-1814.
12. Stainsby WN, Sumners C, Eitzman PD. Effects of adrenergic agonists and antagonists on muscle oxygen uptake and lactate metabolism. J Appl Physiol. 1987;62:1845-1851.
13. Jansson E, Hjemdahl P, Kaijser L. Epinephrine-induced changes in muscle carbohydrate metabolism during exercise in male subjects. J Appl Physiol. 1986;60:1466-1470.
14. Hartling OJ, Trap-Jensen J. Stimulation of beta-adrenoceptors in the exercising human forearm. Clin Physiol. 1982;2:363-371.
15. Isaac L. Clonidine in the central nervous system: site and mechanisms of hypotensive action. J Cardiovasc Pharmacol. 1980;2(suppl 1):515-519.
16. Borg GAV. Psycholophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14:377-381.
17. Jorfeldt L, Wahren J. Leg blood flow during exercise in man. Clin Sci. 1971;41:459-473.
18. Weissman N, Pileggi VJ. Inorganic ions. In: Henry RJ, ed. Clinical Chemistry: Principles and Techniques. New York, NY: Harper & Row: 1974:655.
19. He HB, Deegan RJ, Wood M, Wood AJJ. Optimization of HPLC assay for catecholamines: determination of ideal mobile phase composition and elimination of species dependent differences in extraction recovery of DHBA. J Chromatogr. 1992;374:213-218.
20. 2-stimulation are blunted in chronic heart failure. Clin Pharmacol Ther. 1995;57:142P. Abstract.
21. Wilson JR, Martin JL, Schwartz D, Ferraro N. Exercise intolerance in patients with chronic heart failure: role of impaired skeletal muscle nutritive flow. Circulation. 1984;69:1079-1087.
22. Wilson JR, Ferraro N, Weiner DH. Effect of the sympathetic nervous system on limb circulation and metabolism during exercise in patients with heart failure. Circulation. 1985;72:72-81.
23. Cohn JN, Archibald DG, Ziesche S, and the Veterans Administration Study Group. Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of Veterans Administration Cooperative Study. N Engl J Med. 1986;314:1547-1552.
24. Arnold SB, Williams RL, Ports TA, Baughman RA, Benet LZ, Parmley WW, Chatterjee K. Attenuation of prazosin's effect on cardiac output in chronic heart failure. Ann Intern Med. 1979;91: 345-349.
25. Packer M, Miller J, Gorlin J, Herman MV. Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure. Circulation. 1979;59:531-539.
26. Haskings GJ, Esler MD, Jennings GL, Burton D, Johnson JA, Korner PI. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation. 1986;73:615-621.
27. Hermiller JB, Magorien RD, Leithe ME, Unverferth DV, Leier CV. Clonidine in congestive heart failure: a vasodilator with negative inotropic effects. Am J Cardiol. 1983;51:791-795.
28. Margorien RD, Hermiller JB, Unverferth DV, Leier CV. Regional hemodynamic effects of clonidine in congestive heart failure. J Cardiovasc Pharmacol. 1985;7:91-96.
29. Nayler WG, Price JM, Swann JB, McInnes I, Race D, Lowe TE. Effect of the hypotensive drug ST 155(Catapres) on the heart and peripheral circulation. J Pharmacol Exp Ther. 1968;164: 45-59.
30. Lohson RD, Kaplan HR, Laforce S. An investigation into the bradycardia effects of St-155 2-(2,6-dichlorphenylamino)-2-imidazoline HCl in the anesthetized dog. J Pharmacol Exp Ther. 1969;169:120-131.
31. Leier CV, Heban PT, Huss P, Bush CA, Lewis RP. Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure. Circulation. 1978;58:466-475.
32. Leier CV, Magorien RD, Desch CE, Thompson MJ, Unverferth DV. Hydralazine and isosorbide dinitrate: comparative central and regional hemodynamic effects when administered alone or in combination. Circulation. 1981;63:102-109.
33. Drexler H, Banhardt U, Meinertz T, Wollschlager H, Lehmann M, Just H. Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure: a double-blind, placebo-controlled trial. Circulation. 1989;79:491-502.
34. Bylund-Fellenius A, Walker PM, Elander A, Holm S, Holm J, Schersten T. Energy metabolism in relation to oxygen partial pressure in human skeletal muscle during exercise. Biochem J. 1981;200:247-255.
35. Connett RJ, Gayeski TEJ, Honig CR. Lactate accumulation in fully aerobic working dog gracilis muscle. Am J Physiol. 1984;246: H120-H128.
36. Leier CV. Regional blood flow in human congestive heart failure. Am Heart J. 1992;124:726-737.